Reports and Intelligence: Aspergillosis Global Clinical Trials Review - Size, Share, Global Trends 2014 - PowerPoint PPT Presentation

Loading...

PPT – Reports and Intelligence: Aspergillosis Global Clinical Trials Review - Size, Share, Global Trends 2014 PowerPoint presentation | free to download - id: 6d9685-NTFiM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Reports and Intelligence: Aspergillosis Global Clinical Trials Review - Size, Share, Global Trends 2014

Description:

GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, H2, 2014" provides data on the Aspergillosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aspergillosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Detailed report at: – PowerPoint PPT presentation

Number of Views:117

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Reports and Intelligence: Aspergillosis Global Clinical Trials Review - Size, Share, Global Trends 2014


1

Aspergillosis Global Clinical Trials Review, H2,
2014

Publisher Global Data
No of pages 124
Publish Date Nov 2014
2
Description


GlobalData's clinical trial report,
Aspergillosis Global Clinical Trials Review, H2,
2014" provides data on the Aspergillosis clinical
trial scenario. This report provides elemental
information and data relating to the clinical
trials on Aspergillosis. It includes an overview
of the trial numbers and their recruitment status
as per the site of trial conduction across the
globe. The databook offers a preliminary
coverage of disease clinical trials by their
phase, trial status, prominence of the sponsors
and also provides briefing pertaining to the
number of trials for the key drugs for treating
Aspergillosis. This report is built using data
and information sourced from proprietary
databases, primary and secondary research and
in-house analysis by GlobalData's team of
industry experts. Enquire about report at
http//www.reportsandintelligence.com/enquire-abou
t-report/153543
3
Scope

  • Data on the number of clinical trials conducted
    in North America, South and Central America,
    Europe, Middle-East and Africa and Asia-pacific
    and top five national contributions in each
  • Clinical trial (complete and in progress) data by
    phase, trial status, subjects recruited and
    sponsor type
  • Listings of discontinued trials (suspended,
    withdrawn and terminated)
  • Get all reports of Pharmaceutical category at
    http//www.reportsandintelligence.com/pharmaceutic
    als-market-report

4
Reasons to buy

  • Understand the dynamics of a particular
    indication in a condensed manner
  • Abridged view of the performance of the trials in
    terms of their status, recruitment, location,
    sponsor type and many more
  • Obtain discontinued trial listing for trials
    across the globe
  • Espy the commercial landscape of the major
    Universities / Institutes / Hospitals or
    Companies
  • View detailed report at http//www.reportsandinte
    lligence.com/aspergillosis-global-clinical-trials-
    review-h2-2014-market

5
Table Of Content


Table of ContentsTable of Contents 2List of
Tables 4List of Figures 5Introduction
6Aspergillosis 6Report Guidance 6Clinical
Trials by Region 7Clinical Trials and Average
Enrollment by Country 8Top Five Countries
Contributing to Clinical Trials in Asia-Pacific
10Top Five Countries Contributing to Clinical
Trials in Europe 11Top Countries Contributing to
Clinical Trials in North America 12Top Five
Countries Contributing to Clinical Trials in
Middle East and Africa 13Top Five Countries
Contributing to Clinical Trials in Central and
South America 14 Clinical Trials by G7 Countries
Proportion of Aspergillosis to Infectious Disease
Clinical Trials 15
6
Table Of Content


Clinical Trials by Phase in G7 Countries
16Clinical Trials in G7 Countries by Trial
Status 17Clinical Trials by E7 Countries
Proportion of Aspergillosis to Infectious Disease
Clinical Trials 18Clinical Trials by Phase in E7
Countries 19Clinical Trials in E7 Countries by
Trial Status 20Clinical Trials by Phase 21In
Progress Trials by Phase 22Clinical Trials by
Trial Status 23Clinical Trials by End Point
Status 24Unaccomplished Trials of Aspergillosis
25 Subjects Recruited Over a Period of Time
28Clinical Trials by Sponsor Type 29Prominent
Sponsors 30Top Companies Participating in
Aspergillosis Therapeutics Clinical Trials
31Prominent Drugs 32Latest Clinical Trials News
on Aspergillosis 33
7
Table Of Content


Sep 02, 2014 F2G announces commencement of a
Phase 1 single ascending dose study of a novel
antifungal agent, F901318 33Clinical Trial
Profiles 34Clinical Trial Overview of Top
Companies 34Astellas Pharma Inc. 34Clinical
Trial Overview of Astellas Pharma Inc. 34Pfizer
Inc. 36Clinical Trial Overview of Pfizer Inc.
36Merck Co., Inc. 37 Clinical Trial Overview
of Merck Co., Inc. 37Gilead Sciences, Inc.
38Clinical Trial Overview of Gilead Sciences,
Inc. 38 Get full TOC at http//www.reportsandi
ntelligence.com/aspergillosis-global-clinical-tria
ls-review-h2-2014-market/table-of-contents
8

FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/aspergillosi
s-global-clinical-trials-review-h2-2014-market
Stay With Us
TELEPHONE Direct 1 (617) 674-4143 Toll Free
1 (855) 711-1555E-MAIL sales_at_reportsandintellig
ence.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
About PowerShow.com